B L Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 11.96 Cr
as on 24-10-2024
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 144.65 Cr
as on 24-10-2024
- Satisfied Charges ₹ 121.89 Cr
as on 24-10-2024
- Revenue 20.28%
(FY 2023)
- Profit -31.23%
(FY 2023)
- Ebitda 7.89%
(FY 2023)
- Net Worth 8.81%
(FY 2023)
- Total Assets 18.23%
(FY 2023)
About B L Lifesciences
The Corporate was formerly known as B.L.Life Sciences Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 11.96 Cr.
The company currently has active open charges totaling ₹144.65 Cr. The company has closed loans amounting to ₹121.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at B L Lifesciences Private Limited India is Tarun Arora as COMPANY SECRETARY. Sunil Aggarwal, Ajay Aggarwal, Bhoopendra Shishodia, and One other member serve as directors at the Company.
- CIN/LLPIN
U33112DL1999PTC098641
- Company No.
098641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 1999
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does B L Lifesciences Private Limited offer?
B L Lifesciences Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Laboratory Glassware, Funnel Set, Infusion Syringes & Supplies, Syringes, Measuring Jug, Catheter, Hemodialysis Catheter, Syringe Filter, Medical Filters.
Who are the key members and board of directors at B L Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Aggarwal  | Managing Director | 03-Mar-1999 | Current |
| Tarun Arora | Company Secretary | 08-Dec-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhoopendra Shishodia | Whole-Time Director | 10-Jun-2010 | Current |
| Ajay Aggarwal | Director | 03-Mar-1999 | Current |
| Nonita Kawatra | Whole-Time Director | 30-Oct-2017 | Current |
Financial Performance of B L Lifesciences.
B L Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.28% increase. The company also saw a substantial fall in profitability, with a 31.23% decrease in profit. The company's net worth moved up by a moderate rise of 8.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B L Lifesciences?
In 2023, B L Lifesciences had a promoter holding of 74.91% and a public holding of 25.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Jul 2024 | ₹1.30 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Aug 2022 | ₹1.69 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Mar 2022 | ₹2.25 Cr | Open |
How Many Employees Work at B L Lifesciences?
B L Lifesciences has a workforce of 378 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B L Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B L Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
